As of January 2025 Adaptive Biotechnologies has a market cap of NZ$1.72 Billion. This makes Adaptive Biotechnologies the world's 5631th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | NZ$1.72 B | 4.8% |
2024 | NZ$1.64 B | 46.73% |
2023 | NZ$1.12 B | -34.82% |
2022 | NZ$1.72 B | -70.32% |
2021 | NZ$5.79 B | -48.27% |
2020 | NZ$11.20 B | 101.45% |
2019 | NZ$5.56 B |
On Jan 9th, 2025 the market cap of Adaptive Biotechnologies was reported to be: